Missense mutations in the β3 subunit have a different impact on the expression and function between αIIbβ3 and αvβ3

Blood

Volumn 99, Issue 3, 2002, Pages 931-938

  Tadokoro, Seiji ^a,b   Tomiyama, Yoshiaki ^a,b   Honda, Shigenori ^a,b   Kashiwagi, Hirokazu ^a,b   Kosugi, Satoru ^a,b   Shiraga, Masamichi ^a,b   Kiyoi, Teruo ^a,b   Kurata, Yoshiyuki ^a,b,c   Matsuzawa, Yuji ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA3 INTEGRIN; BETA3 INTEGRIN ALPHA IIB; BETA3 INTEGRIN ALPHA V; CYSTEINE; GLYCINE; HISTIDINE; LEUCINE; MUTANT PROTEIN; PROLINE; SERINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID COMPOSITION; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLANZMANN DISEASE; HUMAN; JAPAN; LIGAND BINDING; MISSENSE MUTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

EID: 0036464723     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.3.931     Document Type: Article

References (51)

1. Integrins: Versatility, modulation, and signaling in cell adhesion
2. Regulation of vascular integrins
3. 3 integrins in hemostasis and vascular biology
4. The platelet membrane glycoprotein IIb-IIIa complex
5. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
6. 3 in smooth muscle cell migration to osteopontin in vitro
7. 3 integrins are osteosclerotic because of dysfunctional osteoclasts
8. Glanzmann's thrombasthenia: The spectrum of clinical disease
9. Glanzmann thrombasthenia: New insights from an historical perspective
10. Hematologically important mutations: Glanzmann thrombasthenia
11. 3 deficiency
12. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel
13. Biogenesis of the vitronectin receptor in human endothelial cell: Evidence that the vitronectin receptor and GPIIb-IIIa are synthesized by a common mechanism
14. Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: Evidence that assembly between pro-GPIIb and GPIIla is a prerequisite for expression of the complex on the cell surface
15. 3 genes that cause Glanzmann thrombasthenia can be distinguished by a simple procedure using transformed B-lymphocytes
16. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets
17. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal anti-body, AP-3
18. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation
19. 3 integrin)
20. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor
21. 2- signaling
22. 1 integrins
23. Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombasthenia
24. Abnormal processing of the glycoprotein Ilb transcript due to a nonsense mutation in exon 17 associated with Glanzmann's thrombasthenia
25. 3 deficiency in Glanzmann thrombasthenia
26. A two-amino acid insertion in the Cys146-Cys167 loop of the αIIb subunit is associated with a variant of Glanzmann thrombasthenia: Critical role of Asp163 in ligand binding
27. Structure of platelet glycoprotein IIIa: A common subunit for two different membrane receptors
28. Molecular basis of CD36 deficiency: Evidence that a 478C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency
29. vβ3
30. 3 export to the platelet surface
31. 3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia
32. Type II Glanzmann thrombasthenia due to a destabilizing amino acid substitution in platelet membrane glycoprotein IIIa
33. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (133) in a Chinese patient with Glanzmann's thrombasthenia
34. 3 requires tyrosine 178 in the αv subunit
35. The integrin β1 subunit associates with the vitronectin receptor αv subunit to form a novel vitronectin receptor in a human embryonic kidney cell line
36. Fibrinogen is a ligand for integrin α4β1 on endothelial cells
37. A β3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation
38. A new variant of Glanzmann's thrombasthenia (Strasbourg I): Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg→214Trp mutation
39. Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor α-subunits and platelet glycoprotein IIb
40. Cloning and expression of a divergent integrin subunit β8
41. 3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients
42. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18)
43. 3
44. Human and bovine endothelial cells synthesize membrane proteins similar to human platelet glycoproteins IIb and IIIa
45. 3-integrins
46. 3
47. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins
48. Heterogeneous mutations in the β subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency
49. Of man and mouse: Leukocyte and endothelial adhesion molecule deficiencies
50. Distinct mutations in two patients with leukocyte adhesion deficiency and their functional correlates
51. Point mutations impairing cell surface expression of the common β subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency